Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05580380 · ClinicalTrials.gov registry record · NA
Addressing Health Disparities in Chronic Low Back Pain With Patient-Clinician Relatedness
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 56
- Enrollment target
NCT05580380: Completed NA study, sponsored by NYU Langone Health.
NCT05580380 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 56 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05580380, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
Study Summary
The primary objective of the current research is to assess the effect of an enhanced patient-clinician relationship when compared to a limited patient-clinician relationship on measures of chronic low back pain and objective functional measures. The second objective is to examine racialized disparities in chronic low back pain among individuals who identify as non-Hispanic Black and non-Hispanic White using a qualitative approach. Lastly, the study team will explore relationships between psychosocial components of low back pain, pain and functional outcomes, and patient-clinician relationship measures.
Primary Outcome
To be measured during the 1-minute lift test, where the participant is asked to lift objects of a certain weight.
Interventions
- OTHER Limited Relationship
- OTHER Enhanced Relationship
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2022-04-01 |
| Est. Completion | 2023-02-01 |
| Phase | NA |
What the finished NCT05580380 record still lists
NCT05580380 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Limited Relationship is the first listed.
NCT05580380 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05580380 about?
NCT05580380 is a clinical study titled "Addressing Health Disparities in Chronic Low Back Pain With Patient-Clinician Relatedness". The primary objective of the current research is to assess the effect of an enhanced patient-clinician relationship when compared to a limited patient-clinician relationship on measures of chronic low back pain and objective functional measures. The second objective is to examine racialized dispari...
What is the current status of trial NCT05580380?
This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2022-04-01. Estimated completion is 2023-02-01.
What interventions are being tested in trial NCT05580380?
The interventions under investigation include: Limited Relationship (OTHER), Enhanced Relationship (OTHER).
Who is sponsoring clinical trial NCT05580380?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05580380's enrollment target sits among peer trials
56 1262nd of 2000 higher than 737 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI